Shin, Hye-Su
Gedi, Vinayakumar
Kim, Joon-Ki
Lee, Dong-ki
Funding for this research was provided by:
Agency for Defense Development through Chemical and Biological Detection Research Center
Article History
Received: 19 November 2018
Accepted: 23 August 2019
First Online: 11 September 2019
Competing Interests
: D.K.L. is a founder and shareholder of OliX Pharmaceuticals.